Comprehensive Cancer Center at Wake Forest University
Winston Salem, North Carolina, United States
Medical center in Winston-Salem, North Carolina
1 Medical Center Blvd, Winston-Salem, NC 27103
About Comprehensive Cancer Center at Wake Forest University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Wake Forest University Health Sciences
199
Alliance for Clinical Trials in Oncology
120
Gynecologic Oncology Group
60
Radiation Therapy Oncology Group
46
Children's Oncology Group
43
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
22
NSABP Foundation Inc
18
National Cancer Institute (NCI)
16
SWOG Cancer Research Network
11
Eastern Cooperative Oncology Group
10
New Approaches to Brain Tumor Therapy Consortium
10
Clinical Trials at Comprehensive Cancer Center at Wake Forest University
During the past decade, Comprehensive Cancer Center at Wake Forest University conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 93 clinical trials were completed, i.e. on
average, 77.5% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 24 clinical trials were completed. i.e. 49%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
1993-06-01
Terminated
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
1992-02-01
2005-09-01
Completed
359
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
1992-05-01
Completed
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
1992-05-01
2006-01-01
Completed
134
SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
1992-09-01
2014-04-01
Completed
348
Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
1992-10-01
2006-01-01
Completed
29
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
1993-05-01
2006-01-01
Completed
635
Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
1996-12-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Comprehensive Cancer Center at Wake Forest University" #1 sponsor was "Wake Forest University Health Sciences" with 199 trials, followed by "Alliance for Clinical Trials in Oncology" with 120 trials
sponsored, "Gynecologic Oncology Group" with 60 trials sponsored, "Radiation Therapy Oncology Group" with 46 trials sponsored and "Children's Oncology Group"
with 46 trials sponsored. Other sponsors include 161 different institutions and
companies that sponsored additional 68 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cancer Center at Wake Forest University"
#1 collaborator was "National Cancer Institute (NCI)" with 544 trials as a collaborator, "Cancer and Leukemia Group B" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Eastern Cooperative Oncology Group" with 13 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 118 different institutions and companies that were
collaborators in the rest 94 trials.
Clinical Trials Conditions at Comprehensive Cancer Center at Wake Forest University
According to Clinical.Site data, the most researched conditions in "Comprehensive Cancer Center at Wake Forest University" are
"Leukemia" (64 trials), "Breast Cancer" (51 trials), "Lymphoma" (51 trials), "Lung Cancer" (45 trials) and "Brain and Central Nervous System Tumors" (41 trials). Many other conditions were trialed in "Comprehensive Cancer Center at Wake Forest University" in a lesser frequency.
Clinical Trials Intervention Types at Comprehensive Cancer Center at Wake Forest University
Most popular intervention types in "Comprehensive Cancer Center at Wake Forest University" are "Drug" (418 trials), "Procedure" (164 trials), "Other" (141 trials), "Radiation" (140 trials) and "Biological" (125 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (91 trials), "cyclophosphamide" (53 trials), "cisplatin" (47 trials), "filgrastim" (44 trials) and "etoposide" (40 trials). Other intervention names were less common.
Clinical Trials Genders at Comprehensive Cancer Center at Wake Forest University
The vast majority of trials in "Comprehensive Cancer Center at Wake Forest University" are
479 trials for "All" genders, 120 trials for "Female" genders and 34 trials for "Male" genders.
Clinical Trials Status at Comprehensive Cancer Center at Wake Forest University
Currently, there are NaN active trials in "Comprehensive Cancer Center at Wake Forest University".
1 are not yet recruiting,
50 are recruiting,
40 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 440 completed trials in Comprehensive Cancer Center at Wake Forest University,
1 suspended trials,
and 77 terminated clinical trials to date.
Out of the total trials that were conducted in Comprehensive Cancer Center at Wake Forest University, 101 "Phase 1"
clinical trials were conducted, 277 "Phase 2" clinical
trials and 146 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 76 trials that are defined as “Not Applicable".